In colorectal cancer, a recent concerted effort in molecular classification carried out by the CRC Subtyping Consortium yielded CMS1–4 subtypes in which the CMS4 subtype was dubbed “mesenchymal”, reflecting the biology of stromal infiltration, TGF-β activation, and angiogenesis. This evidence concerns the gene TGFB1 and colorectal carcinoma.